Anavex Life Sciences Provides Business Update & Reports Fiscal 2022 Second Quarter Financial Results

Anavex Life Sciences to Announce Fiscal 2022 Second Quarter Financial Results on Tues. May 10, 2022

Anavex Life Sciences Announces Presentations at the IRSF Rett Syndrome Scientific Meeting

Anavex Life Sciences Invited to Present at a Neuro & Ophthalmology Conference

Anavex Life Sciences to Present at the Needham Virtual Healthcare Conference

Anavex Life Sciences to Participate in the Cantor Virtual Rare Orphan Disease Summit

Anavex Life Sciences Announces Presentation of Phase 2 Clinical Biomarker Data from PDD study

Anavex Life Sciences to Participate in the Annual Needham Virtual Neuroscience Forum

Anavex Life Sciences Announces Change of Auditor to Grant Thornton LLP

Anavex Life Sciences to Present at the 11th Annual SVB Leerink Global Healthcare Conference

Anavex Life Sciences Provides Business Update & Reports Fiscal 2022 First Quarter Financial Results